Eric Schadt’s Integrative Approach to Predictive Biology
The difference is in the layers. Eric Schadt believes that genome-wide association studies are just the beginning.
Broad Institute Secures Future with $400 Million Endowment
Broad family announces new $400 million endowment.
Merrimack Compound Enters Humans
Their first systems biology product enters human clinical development.
ExonHit Bets on Sapio LIMS
Commercial LIMS has the flexibility for the job.
BMS Seeks to Become ‘Next-Generation Pharma’
Bristol sees the future of biotech and pharma one pearl at a time.
Litigating Patent Obviousness
Insights|Outlook – Pharma should seek out the unpredictable.
Febit Puts Customization to the Test
Launch of RT Analyzer offers bespoke biochips, expanding applications.
Gene Cartography in the Brain
Allen Institute for Brain Science expands its atlas collection.
By expecting less, pharma can get more out of modeling.
Timing and Other Data Storage Trends
Vendors tackle the problems of where to store, when to access, and how to archive data.
Bottlenecks in Drug Discovery
Breaking down silos is a key business initiative.
Pacific Rim Warms Ups to EDC
With evolving language capabilities, EDC is now open to nearly everyone.
Refining Patient Safety
SAS takes a lifecycle view of patient safety data.
IN EVERY ISSUE
Circuit City: Genes and Diseases
By Kevin Davies
FIRST BASE | Identifying disease-associated genes gets more complex and more rewarding.
Cancer Studies Suggest Pathways Are Best Targets
By John Russell
THE RUSSELL TRANSCRIPT | Hopkins researchers call for fighting solid tumors differently.